Company / Interest Expense
Eton Pharmaceuticals, Inc. Interest Expense History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$1.1M
FY2025
5-year range
$98.0K / $1.1M
FY2021-FY2025
Trend
+11.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
$1M in FY2025 with a 5-year CAGR of +61.0%.
Remained stable around $1M over the past 2 years.
Interest Expense over time
Growth rates
- 3-Year CAGR
- +6.2%
- 5-Year CAGR
- +61.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +61.0%, indicating consistent growth.
- In FY2025, interest expense increased 11.0% year-over-year.
- Lowest interest expense in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.63 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.1M | +11.0% |
| FY2024 | $955.0K | -8.3% |
| FY2023 | $1.0M | +17.9% |
| FY2022 | $884.0K | +802.0% |
| FY2021 | $98.0K | +0.0% |
| FY2020 | $98.0K | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026